Qiming Venture Partners USA — Full Portfolio

Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology.

BiotechHealthtechCambridge, US

NBNessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)inJFJean-François Formela(Director)inOCOmmer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)inRARam Aiyar(Chief Executive Officer, President and Director)inTCTodd Chappell(Chief Operating Officer)in

Co-investorsATAtlas VentureMCMC Healthcare VenturesNENew Enterprise Associates (NEA)ALAlexandriaQIQiming Venture PartnersRORock Springs Capital+3 more

Umoja Biopharma develops in vivo CAR T cell cancer therapies using its VivoVec platform, which generates chimeric antigen receptor T cells directly inside a patient's body rather than through the traditional ex vivo process.

BiotechHealthtechSeattle, US

AMAndrew M. Scharenberg(Executive Officer, Director)Philip S. Low(Director)Andrew Scharenberg(Founder)Michael Jensen(Founder)Philip Low(Founder)Ryan Crisman(Founder)

Co-investorsMPMPM BioImpactDCDCVC BioSOSoftBank GroupK2K2 HealthVenturesSOSoftBank Vision FundALAlexandria+2 more

BiotechNewton, US

Katharine Yen(Executive Officer, Director)KYKate Yen(Founder)inChristopher Guiffre(Executive Officer)

BoardAlon Lazarus(Director)AFAnna French(Director)inACAlexandra Cantley(Director)in

Co-investorsDCDCVC (Data Collective)APApollo Health VenturesBRBrightEdgeDCDCVC BioPOPolaris PartnersQIQiming Venture Partners

Boulder provides medication-assisted treatment for addiction through licensed specialists who prescribe buprenorphine, supported by dedicated care teams offering medical care, peer recovery coaching, and care coordination accessible via a digital platform.

Digital HealthHealthtechMental HealthBoulder, US

Stephanie Papes(Cofounder)Stephanie Strong(Founder)Jordan Nof(Director)Frank Ingari(Director)Josh Kopelman(Director)

Co-investorsACAcumen AmericaADAdvance Venture PartnersALAlumni VenturesFIFirst Round CapitalGAGaingelsGRGreycroft+6 more

Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company developing clinical-stage therapies for neuropsychiatric disorders including schizophrenia, movement disorders, and treatment-resistant depression.

BiotechDigital HealthHealthtechMedical DevicesCambridge, US

Co-investorsCLClal Biotechnology IndustriesSLSlater Technology FundACAccess IndustriesATAtlas VentureCOCowen Healthcare InvestmentsNONovartis Institute for Biomedical Research+1 more

Dualitas Therapeutics develops bispecific antibody therapies that pair a proprietary proximity engager arm with an antibody against a therapeutic target, using its DualScreen discovery engine to identify synergistic target combinations.

BiotechDeep TechSouth San Francisco, US

Greg Lazar, Ph.D.(Co-Founder and Chief Scientific Officer)FHForbes Huang(Co-Founder, Chief Operating Officer & Chief Business Officer)inGLGreg Lazar(Co-Founder & Chief Scientific Officer)inRichard Murray(Executive Officer, Director)KDKarim Dabbagh(Chief Executive Officer, Board Member)in

BoardALAlicia Levey(Director)

Co-investorsQIQiming Venture PartnersSVSV Health InvestorsVEVersant VenturesALAlexandriaDEDementia Discovery FundQIQiming Healthcare

Empirico is a San Diego-based clinical-stage biotech that uses human genetics data and computational methods to discover disease targets and develop siRNA and antibody therapeutics.

BiotechSan Diego, US

Omri Gottesman(Executive Officer, Director)inShannon Bruse(Executive Officer, Director)inBrian Cajes(Executive Officer)in

BoardJohn Hamer(Director)Kolluri Swaroop(Director)

Co-investorsDCDCVC (Data Collective)FEFelicis VenturesDCDCVC BioQIQiming Venture Partners

Fuze Health operates a unified digital healthcare platform spanning digital pharmacy (FuzeRx), clinical services such as diagnostics, screening and genetics (Fuze Services), and data and technology tools (Fuze Technologies).

AI & Machine LearningDigital HealthHealthtechSaaS

Co-investorsFJFJ LabsHLHLM Investment PartnersILIllumina VenturesK2K2 HealthVenturesOLOlive Tree CapitalSOSoftBank Vision Fund+2 more

Vaccine development platform using computationally designed synthetic virus-like particles

BiotechSeattle, US

Charles Richardson(Senior Vice President, Technical Operations)Adam K. Simpson(President and Chief Executive Officer)Niranjan Kanesa-thasan(Chief Medical Officer)Douglas A. Holtzman(Chief Scientific Officer and Secretary)Cassia Cearley(Treasurer, Chief Business Officer)

BoardPKPeter Kolchinsky(Director)in

Co-investorsRARA CapitalSASanofi VenturesVIViking GlobalQIQiming HealthcareQIQiming Venture Partners

Kezar Life Sciences is a clinical-stage biotechnology company developing small-molecule therapeutics for immune-mediated diseases and cancer.

BiotechSouth San Francisco, US

JFJohn F. Fowler(Executive Officer, Director)inChristopher J. Kirk(Executive Officer, Director)

BoardDr. Gerald Chan(Director)Dr. Jean-Pierre Sommadossi(Director)

Co-investorsBABay City CapitalCHChiesi VenturesPAPappas CapitalSOSolasta VenturesCOCowen Healthcare InvestmentsECEcoR1 Capital+1 more

Madaket operates a SOC 2 Type 2-compliant platform that ingests, standardizes, validates, and synchronizes provider data for the healthcare provider–payer ecosystem.

Data & InfrastructureDigital HealthHealthtechSaaSCambridge, US

James P. Dougherty(Executive Officer, Director)Ted Achtem(Chief Data Officer)inMegan Schmidt(CEO)inJerry Held(Director)Archibald Cox(Director)Jeannine Dahling(Chief Operating Officer)

Co-investorsF-F-Prime CapitalRARaptor GroupWAWaterline VenturesEXExperian VenturesQIQiming Venture Partners

MyHealthTeam builds social networks for people diagnosed with chronic health conditions, connecting patients so they can share experiences and manage their health.

Digital HealthHealthtechSocialSan Francisco, US

EPEric Peacock(Co-Founder and CEO)inMRMary Ray(Co-Founder and COO)inELElizabeth Luce(EVP Partnerships and Partner Operations)inTMTomas Melian(SVP Marketing)inDWDavid Wygant(SVP Product)inDGDante Gaudio(EVP of Community)in

Co-investors50500 GlobalEVEvolution VC PartnersSASand Hill AngelsTHThe Westly GroupTSTSVCADAdams Street Partners+2 more

Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to restore the function of polycystin 1 and 2 proteins in autosomal dominant polycystic kidney disease (ADPKD).

BiotechHealthtechBerkeley, US

Jeremy Reiter(Scientific Co-Founder)Markus Delling(Scientific Co-Founder)TGThomas Gustafson(Executive Officer)inECEmily Conley(Executive Officer, Director)in

BoardECEvan Caplan(Director)inCharlotte McKee(Director)

Co-investors5A5AM VenturesOROrbiMedATAtlas VentureQIQiming Venture Partners

Rhino builds a system of record for enterprise business logic, rules, and decisions that are typically scattered across legacy systems and processes.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareAlexandria, US

Adam Branch(Executive Officer, Director, Promoter)in

BoardHarrison Touati(Director)Jon Galitzer(Director)

Co-investorsKOKoch Disruptive TechnologiesLILionBirdMIMitsui Global InvestmentALAlleyCorpARArkin Digital HealthGAGaingels+3 more

Rhino Federated Computing provides enterprise software infrastructure enabling organizations to run AI, analytics, and data workflows across distributed data environments while preserving privacy and security.

AI & Machine LearningData & InfrastructureEnterprise SoftwareBoston, US

IDIttai Dayan(Dr.)inYBYuval Baror(Founder)inChristopher Laws(Executive Officer)

BoardEMEdward Michael(Director)inIBIvneet Bhullar(Director)in

Co-investorsALAlleyCorpE1E12 Venture Capital, LlcFUFusionLILionBirdMAMana VenturesMIMitsui Global Investment+6 more

Satellos is a biotechnology company developing oral small molecule therapies that restore the body's natural muscle regeneration process by targeting muscle stem cell asymmetric division.

BiotechMedical DevicesToronto

Franklin Berger(Director)Frank Gleeson(Executive Officer, Director, Promoter)Michael Robert Cross(Executive Officer)William McVicar(Director)Brian Bloom(Director)Elizabeth Williams(Executive Officer)

Stellular Bio develops platelet-derived regenerative biologic (PRB) therapeutics to treat ocular surface disease, initially targeting Sjogren's syndrome-related dry eye.

BiotechMedical Devices

Co-investorsEQEQx Fund

Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions

BiotechLouisville, US

Suzanne Ildstad(Executive Officer, Director)SRScott Requadt(Executive Officer, Director)Geoff Mackay(Director)Francois Nader(Director)

BoardSASandip Agarwala(Director)inMMMark McDade(Director)in

Co-investorsAIAisling CapitalKEKeyhorse CapitalLOLongitude CapitalVIViking GlobalBLBlackstone Life SciencesCICitadel+3 more

Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye.

BiotechDigital HealthHealthtechLongevityMedical DevicesWarren, US

HBHENRIC BJARKE(Chief Executive Officer)in

Co-investorsADAdBio partnersF-F-Prime CapitalSOSofinnova PartnersQIQiming Venture Partners

WindMIL Therapeutics is a clinical-stage biotechnology company developing cell-based immuno-oncology therapies using marrow-infiltrating lymphocytes (MILs), T cells extracted from a cancer patient's bone marrow that are activated and expanded before being returned to the patient.

BiotechMedical DevicesPrinceton, US

Ivan Borrello(Founder)KNKimberly Noonan(Founder)in

BoardBrian Halak(Executive Officer, Director)

Co-investorsQIQiming Healthcare